Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Hippokratia. 2009 Jan;13(1):9-19.

Non alcoholic fatty liver disease and metabolic syndrome.

Author information

  • 1Metabolic Disease Unit, 2nd Internal Medicine Department, Aristotle University of Thessaloniki, Hippokratio Hospital, Thessaloniki, Greece.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic entity increasingly recognized as a major health burden in developed countries. It includes a spectrum of liver damage ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), advanced fibrosis, and rarely, progression to cirrhosis. Recent studies emphasize the role of insulin resistance, oxidative stress and subsequent lipid peroxidation, proinflammatory cytokines, adipokines and mitochondrial dysfunction in the development and progression of NAFLD. Furthermore, accumulating evidence supports an association between NAFLD and metabolic syndrome. Although the data are mainly epidemiological, the pathogenesis of NAFLD and metabolic syndrome seems to have common pathophysiological mechanisms, with focus on insulin resistance as a key factor. This review summarizes the current knowledge on the epidemiology, pathophysiology and diagnosis of both NAFLD and metabolic syndrome and the findings that strongly support the association of nonalcoholic fatty liver disease as a possible component in the cluster of metabolic syndrome.

KEYWORDS:

metabolic syndrome; non alcoholic fatty liver disease; non alcoholic steatohepatitis

Comment in

PMID:
19240815
[PubMed]
PMCID:
PMC2633261
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1:
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk